RB

Ravidev Baldev Bhatt

Active Director Managing Director DIN 07808914
DIN 07808914 First appointment Mar 2019 Primary industry Food And Beverages
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2019
Shareholding value β€’β€’β€’β€’ Premium profile

About Ravidev Baldev Bhatt

Data last updated:

Ravidev Baldev Bhatt is a Managing Director at Medprime Pharmaceuticals Private Limited (since 2019). The company operates in Food And Beverages.

DIN 07808914
Primary Designation Managing Director
Industry Food And Beverages
First Appointment 07 Mar 2019
Oldest Company Age 7 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Managing Director07 Mar 20192019Active

Board colleagues of Ravidev Baldev Bhatt

NameDINCompanyDesignation
Suneel Mishra08383458Medprime Pharmaceuticals Private LimitedWhole-Time Director

Directorship timeline

Open interactive timeline →
Medprime Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Ravidev Baldev Bhatt

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ravidev Baldev Bhatt

Ravidev Baldev Bhatt currently holds 1 directorship: Medprime Pharmaceuticals Private Limited (Managing Director, since 07 Mar 2019).

Ravidev Baldev Bhatt was first appointed on 07 Mar 2019 as Managing Director at Medprime Pharmaceuticals Private Limited.

The current boards of Ravidev Baldev Bhatt's companies include Suneel Mishra (Medprime Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available